SCHEMBL6709048

SCHEMBL6709048

O=C(Nc1ccc(Cl)cc1-c1nnn[nH]1)c1noc2cc(NS(=O)(=O)c3ccc(F)cc3)ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
HTT P42858 1/20 0.38
HIF1A Q16665 2/20 0.38
TDP1 Q9NUW8 1/20 0.37
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 2/20 0.37
POLB P06746 2/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
ERAP1 Q9NZ08 1/20 0.37
BRD4 O60885 1/20 0.37
HSD17B3 P37058 1/20 0.37
HSD17B2 P37059 1/20 0.37
MEN1 O00255 2/20 0.36
HPGD P15428 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710201 0.94 TDP1 (0.39) KMT2AMAPTLMNATP53HTT
SCHEMBL6713276 0.92 HIF1A (0.43) KMT2AMAPTLMNATP53HIF1A
SCHEMBL6711755 0.92 ALDH1A1 (0.36) KMT2AMAPTTP53ALDH1A1KDM4E
SCHEMBL6711507 0.89 MEN1 (0.39) KMT2AALDH1A1KDM4EPOLBGLA
SCHEMBL6708879 0.87 HIF1A (0.41) KMT2AHTTHIF1AALDH1A1KDM4E
SCHEMBL6713533 0.87 HIF1A (0.40) KMT2AMAPTLMNATP53HTT
SCHEMBL6710186 0.86 HIF1A (0.43) KMT2AMAPTHIF1ATDP1ALDH1A1
SCHEMBL6707828 0.85 SLC10A6 (0.36) KMT2AMAPTHIF1AALDH1A1GLA
SCHEMBL6708056 0.85 HIF1A (0.46) KMT2AHIF1AALDH1A1KDM4EPOLB
SCHEMBL6709254 0.83 GPR27 (0.37) KMT2AHIF1AALDH1A1KDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 KMT2A 3181/4885MAPT 4754/4885LMNA 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.